Centro de Imagem Diagnósticos S.A (AALR3) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.071x

Based on the latest financial reports, Centro de Imagem Diagnósticos S.A (AALR3) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$78.10 Million ≈ $15.32 Million USD) by net assets (R$1.10 Billion ≈ $215.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check AALR3 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Centro de Imagem Diagnósticos S.A - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Centro de Imagem Diagnósticos S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. See AALR3 net asset value for net asset value and shareholders' equity analysis.

Centro de Imagem Diagnósticos S.A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Centro de Imagem Diagnósticos S.A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Darya-Varia Laboratoria Tbk
JK:DVLA
0.063x
Singha Estate Public Company Limited
BK:S
0.022x
Nava Nakorn Public Company Limited
BK:NNCL
-0.053x
FPX Nickel Corp
V:FPX
-0.011x
Bionet
TWO:1784
0.013x
Wellspire Holdings Berhad
KLSE:0271
-0.129x
Alcidion Group Ltd
AU:ALC
0.113x
Cypherpunk Technologies Inc.
NASDAQ:CYPH
-0.043x

Annual Cash Flow Conversion Efficiency for Centro de Imagem Diagnósticos S.A (2010–2024)

The table below shows the annual cash flow conversion efficiency of Centro de Imagem Diagnósticos S.A from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Centro de Imagem Diagnósticos S.A (AALR3) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 R$1.14 Billion
≈ $223.06 Million
R$-41.02 Million
≈ $-8.05 Million
-0.036x -133.30%
2023-12-31 R$943.99 Million
≈ $185.23 Million
R$102.30 Million
≈ $20.07 Million
0.108x -43.19%
2022-12-31 R$981.92 Million
≈ $192.67 Million
R$187.30 Million
≈ $36.75 Million
0.191x +54.70%
2021-12-31 R$1.21 Billion
≈ $237.31 Million
R$149.13 Million
≈ $29.26 Million
0.123x +28.02%
2020-12-31 R$1.22 Billion
≈ $240.11 Million
R$117.86 Million
≈ $23.13 Million
0.096x -40.42%
2019-12-31 R$1.32 Billion
≈ $259.01 Million
R$213.41 Million
≈ $41.87 Million
0.162x +30.36%
2018-12-31 R$1.30 Billion
≈ $255.03 Million
R$161.19 Million
≈ $31.63 Million
0.124x +17.39%
2017-12-31 R$1.27 Billion
≈ $249.25 Million
R$134.19 Million
≈ $26.33 Million
0.106x +62.12%
2016-12-31 R$1.21 Billion
≈ $237.80 Million
R$78.97 Million
≈ $15.50 Million
0.065x -51.54%
2015-12-31 R$733.00 Million
≈ $143.83 Million
R$98.56 Million
≈ $19.34 Million
0.134x +109.55%
2014-12-31 R$743.32 Million
≈ $145.85 Million
R$47.69 Million
≈ $9.36 Million
0.064x +4.79%
2013-12-31 R$279.49 Million
≈ $54.84 Million
R$17.11 Million
≈ $3.36 Million
0.061x -63.19%
2012-12-31 R$234.93 Million
≈ $46.10 Million
R$39.07 Million
≈ $7.67 Million
0.166x +29.64%
2011-12-31 R$257.14 Million
≈ $50.46 Million
R$32.99 Million
≈ $6.47 Million
0.128x -58.17%
2010-12-31 R$35.66 Million
≈ $7.00 Million
R$10.94 Million
≈ $2.15 Million
0.307x --

About Centro de Imagem Diagnósticos S.A

SA:AALR3 Brazil Diagnostics & Research
Market Cap
$104.61 Million
R$533.13 Million BRL
Market Cap Rank
#19131 Global
#182 in Brazil
Share Price
R$3.50
Change (1 day)
+2.94%
52-Week Range
R$2.56 - R$6.76
All Time High
R$24.30
About

Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood cou… Read more